MicroRNAs and Their Targets Could Have a Crucial Role in Breast Cancer Drug Resistance: A Bioinformatics Research
Öz
Background: MicroRNAs(miRNAs) have been demonstrated to contribute to cancer development by playing essential roles in processes including proliferation, migration, invasion, and metastasis. One of the most serious issues in breast cancer (BRCA) is drug resistance. Recent research suggests that miRNAs may possibly play a role in drug resistance. Using diverse datasets and in silico approaches, we focused on the BRCA/drug resistance/miRNA/mRNA link in our study.
Methods: GSE73736 and GSE71142 geo datasets (for miRNAs) and GSE162187 geodataset (for genes) were obtained from the GEO database to detect differently expressed miRNAs and genes using the R software “LIMMA” package. Potential target genes of screened differentially expressed miRNAs (DE-miRNAs) were predicted using miRMap, miRTarbase, and miRNet tools. Differently expressed genes (DE-genes) were filtered and common DE-genes were identified via TCGA data and miRNet. Afterward, Enrichr, and Funrich tools were used to perform GO annotation and KEGG pathway enrichment analysis. KMplot and GEPIA2 web tools were utilized to investigate further hub miRNAs and genes' expression and prognostic effects.
Results: 3 miRNAs that were considerably downregulated and had prognostic significance in BRCA were identified using the criteria defined in the investigated geo datasets. MiR-586, which is expected to be more closely linked to BRCA, has been found to have the ability to target 5 genes involved in BRCA resistance to therapy. GO, KEGG, and survival analysis showed that the probable target genes of miR-586 could be closely connected to BRCA.
Conclusion: In this study, a comprehensive BRCA-drug resistance-miRNA-gene network was established and new targets for the treatment and prognosis of BRCA were revealed using bioinformatics data.
Anahtar Kelimeler
Kaynakça
- Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P, Li Y. Exosomes and breast cancer drug resistance. Cell Death Dis. 2020; 11(11):987.
- Kaya M, Suer İ. The Effect of miR-34a-5p on Overexpressed AML Associated Genes. Journal of Istanbul Faculty of Medicine. 2023; 86(1):59-68.
- Kaya M, Karataş ÖF. The relationship between larynx cancer and microRNAs. Van medical journal. 2020; 27(4):535-41.
- Kaya M, Suer I, Ozgur E, Capik O, Karatas OF, Ozturk S, et al. miR-145-5p suppresses cell proliferation by targeting IGF1R and NRAS genes in multiple myeloma cells. Turkish Journal of Biochemistry. 2023; 48(5):563-9.
- Capik O, Sanli F, Kurt A, Ceylan O, Suer I, Kaya M, et al. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis. Prostate Cancer and Prostatic Diseases. 2021; 24(3):891-902.
- Cosentino G, Plantamura I, Tagliabue E, Iorio MV, Cataldo A. Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay. Cancers (Basel). 2021; 13(15).
- Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019; 20(5):1836-52.
- Luna Buitrago D, Lovering RC, Caporali A. Insights into Online microRNA Bioinformatics Tools. Noncoding RNA. 2023; 9(2).
- Kaya M. A Bioinformatics Approach to Male Infertility, MicroRNAs, and Targeted Genes. Ahi Evran Medical Journal. 2023; 7(3):296-303.
- Banwait JK, Bastola DR. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics. Adv Drug Deliv Rev. 2015; 81:94-103.